Sinclair Pharma case study

Client:

Sinclair Pharma plc is an international specialty pharmaceutical company providing solutions to treat wounds, dermatological and oral diseases through advanced surface technology and innovative delivery systems. It has a growing sales and marketing operation that is present in France, Italy, Germany and Spain, and a complementary marketing partner network that spans more than 90 countries. Sinclair Pharma plc is listed on the London Stock Exchange and Euronext Paris.

Imprima product:

Imprima’s full Corporate Reporting solution was used including content consultancy, design, typesetting, production and mailing of Sinclair Pharma’s Annual Report. A fully interactive online version of the report was also developed using Imprima’s iReports.

Client benefits:

  • Using iReports, Sinclair Pharma’s Annual Report was developed into an interactive microsite and uploaded onto the company’s website. This gave existing and potential investors fast and convenient access to the report with the ability to focus on the areas of information that interest them the most. Using iReports enabled Sinclair Pharma to keep the print run to a minimum thus reducing costs and their carbon footprint. It also encouraged more traffic to their website.
  • With expert content consultancy from Imprima, Sinclair Pharma’s Annual Report was professionally and creatively presented, and an impressive representation of their brand.
  • Imprima’s in-house typesetting capability – the largest in Europe – meant that proofs were turned around quickly, reducing timescales.
  • With Imprima’s experienced and detailed project management, the report was designed and printed on time and within budget to the highest quality standards.

What clients say Read more testimonials

“In terms of the annual report, I think that especially given the unusual circumstances of the project, which was carried out when the company was undergoing internal restructuring, as well as a change in the personnel involved in the coordination of the report itself, we all felt that the high level of support given at your end was key to the success of the project.

We were impressed from the outset by the ideas and advice you gave us in terms of the key messaging and design, and also by the high level of commitment demonstrated throughout the project. The new iDrafts tool strikes us as a great way to speed up the editing process and is definitely something we would be keen to use in future.

Lastly we were very pleased with the result – and especially with the iReports HTML version, which we all felt was really well laid out and easy to navigate our way around the pages.”

Sinclair Pharma plc


News

Lloyds Banking Group Rights Issue - Lloyds Banking Group plc partners with Imprima on its £13.5bn Rights...read more